Reliance Medical
Reliance Medical, headquartered in Great Britain, is a leading provider in the medical supplies industry, specialising in innovative healthcare solutions. Founded in 2001, the company has established a strong presence across the UK and Europe, focusing on essential products for both healthcare professionals and patients. With a diverse portfolio that includes wound care, surgical instruments, and diagnostic equipment, Reliance Medical is recognised for its commitment to quality and reliability. The company’s unique approach combines advanced technology with user-friendly designs, ensuring that their products meet the highest standards of safety and efficacy. Over the years, Reliance Medical has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. Its dedication to customer satisfaction and continuous improvement has solidified its reputation as a market leader in medical supplies.
DitchCarbon Score
How does Reliance Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Reliance Medical's score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Reliance Medical's reported carbon emissions
In 2024, Reliance Medical reported total carbon emissions of approximately 36,900,275,000 kg CO2e, comprising about 36,900,027,000 kg CO2e from Scope 1 and about 781,764,000 kg CO2e from Scope 2 emissions. This represents a slight decrease from 2023, where total emissions were approximately 37,095,658,000 kg CO2e, with Scope 1 emissions at about 37,095,658,000 kg CO2e and Scope 2 emissions at about 850,070,000 kg CO2e. Reliance Medical has disclosed emissions data for Scope 1 and Scope 2 but has not reported any Scope 3 emissions. The company has not set specific reduction targets or climate pledges, indicating a potential area for future commitment. The emissions intensity for Scope 1 and Scope 2 in terms of physical output was reported at 482.0 kg CO2e per tonne in 2024, slightly down from 493.0 kg CO2e per tonne in 2023. As of now, Reliance Medical does not inherit emissions data from any parent or related organizations, and all reported figures are based solely on its own operations. The company’s climate commitments and reduction initiatives remain unspecified, highlighting an opportunity for enhanced sustainability strategies in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 37,095,658,000 | 00,000,000,000 |
| Scope 2 | 850,070,000 | 000,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Reliance Medical is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
